Drugs / OMS302
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00721695 | May 2008 → Feb 2009 | cataract | Omeros Corporation | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01193127 | Jul 2010 → Jan 2011 | cataract | Omeros Corporation | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02132312 | Jul 2014 → Sep 2016 | cataract | Omeros Corporation | Completed | No outcome recorded |
| Phase 3 | NCT01454063 | Sep 2011 → Mar 2012 | — | Omeros Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OMS302 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01454063 ↗ |
| Route | Other | “being developed as an irrigation solution during intracameral lens replacement surgical procedures of the eye” NCT00721695 ↗ |